FAR420 - BIOTEKNOLOGI FARMASEUTIKAL
(PHARMACEUTICAL BIOTECHNOLOGY)
[ 3 Unit ]
*** Sumber data : SMUP
📖 Sinopsis Kursus / Course Synopsis ▼
Kursus ini meneroka penggunaan produk bioteknologi seperti protein, terapi berasaskan asid nukleik, dan imunoterapeutik seperti ubat yang dipreskripsi. Kursus ini meliputi teknologi DNA rekombinan, kejuruteraan gen, proses pengeluaran biofarmaseutikal, isu kawal selia, serta aspek etika, undang-undang dan sosial produk bioteknologi, termasuk kelulusan ubat.
This course explores the use of biotechnological products like protein, nucleic acid-based therapy, and immuno-therapeutics as prescribed drugs. This course covers recombinant DNA technology, gene engineering, biopharmaceutical production processes, regulatory issues, as well as ethical, law, and social aspects of biotechnological products, including drug approval.
*** Sumber data : SPBPK
📋 Hasil Pembelajaran Kursus / Course Learning Outcomes (HPK / CLO) ▼
| HPK / CLO | Penerangan HPK / CLO Description | Kaedah Pengajaran / Teaching Method | Pemetaan / Mapping: PLO USM |
Pemetaan / Mapping: LT |
|---|---|---|---|---|
| CLO1 | Explain basic concept of recombinant DNA technology and cell culture technology in the production of biotechnology-based (biopharmaceuticals) prescribed drugs. | Kuliah | PLO1 | C2 |
| CLO2 | Generate educational articles related to biopharmaceuticals for community sharing. | Kuliah | PLO2 | C3 |
| CLO3 | Explain formulation stategies, identify stability issues related to biologics and dispensing of biopharmaceutical products. | Kuliah | PLO1 | C2 |
| CLO4 | Explain regulatory issues related to biopharmacutical drug approval, and various issues related to the ethical, law and social aspects of biotechnological-based products | Kuliah | PLO1 | C2 |
*** Sumber data : SPBPK
📊 Penilaian / Assessment ▼
| Komponen Penilaian / Assessment Component | Peratusan / Percentage |
|---|---|
| Kerja Kursus / Course Work | 40% |
| Peperiksaan Akhir (PA) / Exam Work | 60% |
*** Sumber data : SMUP